Results 111 to 120 of about 179,934 (163)

Epigenetic Repression of <i>TP53</i> Transcription Underlies Cancer Cell Persistence for Carboplatin Resistance in Non-Small Cell Lung Cancer. [PDF]

Biomol Ther (Seoul)
Ha S, Kim WY.
europepmc   +1 more source

Epidemiological risk factors and inferred p53 pathway dysregulation in Esophageal squamous cell carcinoma in the Somali population. [PDF]

Discov Oncol
Rooraye HM, Lukman Y, Suppian R, Ali A, Che Lah CI, Ramli RR.   +5 more
europepmc   +1 more source

Molecular biomarkers as key determinants of outcome in mantle cell lymphoma: results from the FIL V-RBAC trial. [PDF]

Blood Adv
Moia R, Almasri M, Carazzolo ME, Cividini L, Tabanelli V, Melle F, Genuardi E, Cosentino C, Maher N, Bellia M, Mahmoud AM, Evangelista A, Quaglia FM, Fiori S, Bomben R, Tisi MC, Riva M, Merli A, Rotondo F, Corradini P, Farina L, Castellino C, Castellino A, Zilioli VR, Muzi C, Piazza F, Re A, Hohaus S, Rossi FG, Musuraca G, Di Rocco A, Puccini B, Sciarra R, Ballerini F, Cavallo F, Bruna R, Moioli A, Bernardelli A, Patti C, Olivieri J, Bianchi B, Loseto G, Spina M, Usai SV, Stefani PM, Stelitano C, Drandi D, Zinzani P, Ferreri AJM, Balzarotti M, Ladetto M, Ferrero S, Pileri SA, Gaidano G, Visco C.   +54 more
europepmc   +1 more source

Second-Line Therapy Following Osimertinib in Metastatic EGFR-Mutated Non-Small-Cell Lung Cancer at an Academic Medical Center. [PDF]

Cancer Rep (Hoboken)
Rafizadeh M, Bogdan S, Lee J, Garcia C, Saxena A, Zhou K, Parang B.   +6 more
europepmc   +1 more source

Interpretation of p53 immunohistochemical stain of TP53-mutated myeloid neoplasms. [PDF]

Front Oncol
Barwari N, Morrow WP, Evans JK, Rosenthal N, Beaty MW, Hsi E, Insuasti-Beltran G, Maracaja DLV.   +7 more
europepmc   +1 more source

High-risk features in adult patients with B-cell acute lymphoblastic leukemia: redefining risk in the era of targeted immunotherapy. [PDF]

Blood Res
Baek DW.
europepmc   +1 more source

<i>TP53</i> mutation drives unique transcriptional and functional vulnerabilities independent of del(17p) in multiple myeloma. [PDF]

iScience
Tsallos D, Ikonen N, Miettinen JJ, Majumder MM, Eldfors S, Västrik I, Parsons A, Suvela M, Dunphy K, Dowling P, Bazou D, O'Gorman P, Lievonen J, Silvennoinen R, Anttila P, Heckman CA.   +15 more
europepmc   +1 more source

Integrating Next Generation sequencing into the risk assessment of primary myelofibrosis. [PDF]

Hematol Transfus Cell Ther
Reis-Vieira R, da Costa JB, Coutinho D, Arcuri LJ, D'Andrea M, Robledo ML, Daumas AH, Solza C, Boroni M, Zalcberg I, Monte-Mór BDCR.   +10 more
europepmc   +1 more source

Anthracycline and antimetabolite, trigger distinct resistance mechanisms in TP53^mut AML. [PDF]

Cell Death Discov
Raghuwanshi S, Gartel AL.
europepmc   +1 more source